Pallas Health review

Pallas Health now has a more relevant service for women than its earlier general GLP-1 catalog: it publishes a menopause hormone-therapy program alongside compounded and brand-name weight medication. Its billing has also changed. New compounded plans have a four-week renewal option, rather than the older assumption that every patient must pay for a twelve-week block.

Those changes make the current plan worth reassessing on its own terms. The lowest first-period price remains an introductory offer, and hormone treatment is a separate purchase. This review evaluates Pallas's current public services and purchase policies; it does not imply treatment experience or independent verification of every company claim.

What does the current GLP-1 plan cost?

The homepage lists compounded semaglutide at $139 for the first four weeks, then $199 every four weeks. Tirzepatide is $179 for the first four weeks, then $299 every four weeks. The continuing amounts are the useful comparison with another provider's standard plan.

A four-week cycle produces thirteen periods over 52 weeks. With one introductory period and twelve unchanged renewals, the first 52 weeks would total $2,527 for semaglutide or $3,767 for tirzepatide. This arithmetic compares the advertised schedule; it does not guarantee how long an individual will use treatment.

Pallas also advertises annual plans at equivalents of $139 per month for semaglutide and $239 for tirzepatide. Confirm the upfront total, supply and renewal terms before choosing a long commitment. The annual equivalent is different from paying that amount every month on a flexible plan.

The site says provider visits, follow-ups, messaging, dose adjustments and shipping are included, without a separate membership fee. FDA-approved brand pens are separately available for cash payment, starting at $1,069 monthly in the public overview. They are not included at compounded prices, and Pallas says it does not bill insurance.

What changed about approval and payment?

The terms distinguish purchases made on or after September 8, 2026 from older deposit arrangements. For the current plans, checkout saves the payment method and does not charge until a licensed clinician prescribes. If the clinician declines or the patient cancels before the decision, nothing is charged.

That is more specific than a generic money-back promise, but the selected order still needs to show the same arrangement. Once the prescription is issued, the order becomes final under the current terms. Medication preparation, delivery and cancellation of later renewal are separate stages.

The process is online assessment, clinician review and fulfillment if appropriate. Pallas describes asynchronous care in 43 states, with one video visit required in Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and Washington, D.C. National service does not mean every patient skips a live appointment.

Who provides care and follow-up?

The company names Dr. Ana Lisa Carr in its medical-team presentation and describes care through licensed clinicians. Its public program includes messaging, refill check-ins and dose adjustments, with an app for tracking orders, doses, weight and mood.

The terms distinguish Pallas's platform from the independent clinicians and pharmacies responsible for treatment and dispensing. Ask who will actually prescribe, whether the same clinician can follow both weight and hormone plans and how live follow-up is arranged. An app is useful access, but does not by itself establish a specific clinician response time.

The general weight-loss pages do not set out an included laboratory schedule for every patient. If testing is requested, confirm who orders, reviews and pays for it. A hormone service may have different screening and monitoring requirements from the GLP-1 plan, so those benefits should not be transferred between programs without confirmation.

What does the menopause program offer?

Pallas's current women's-hormone page describes clinician-prescribed estradiol, estriol and progesterone. The listed formats include a combined cream, progesterone capsules, an estradiol patch and vaginal estradiol. It advertises a twelve-week supply from $43 per month equivalent, with provider care included.

That makes hormone care an actual published offering rather than a coming-soon category. The starting figure does not establish that every formulation, multiple prescriptions or weight medication is included for the same price. Obtain the exact product, total payment and renewal interval for the treatment your clinician recommends.

A woman considering both programs should ask how records and prescriptions are coordinated and whether one clinician oversees the full plan. Our GLP-1 and HRT guide explains those questions. A hormone catalog does not mean HRT is appropriate for everyone or that weight loss replaces assessment of menopause symptoms.

For PCOS, the reviewed pages do not establish a comprehensive fertility or menstrual-care pathway. Our GLP-1 and PCOS guide helps distinguish general weight management from those wider needs.

Which medication will you receive?

Pallas separates compounded injections from approved branded products. Its current site says compounded preparations are made by U.S.-licensed pharmacies and are not FDA-approved. Product illustrations and dose calculators should not replace the actual pharmacy label and prescribing instructions.

Request the assigned pharmacy, ingredient list, concentration, quantity and storage guidance before fulfillment. The fact that several pharmacies participate in a network does not establish which one prepares an individual order. Our compounded versus brand-name guide explains why the product and route need to be compared directly.

Can you cancel or receive a refund?

Current terms allow free cancellation through the account or support, effective at the end of the current period. Before prescription issuance, any charge is refundable and no new-plan payment should have occurred. Once the prescription is issued, the order is final and the current cycle is not prorated or refunded; cancellation stops future charges.

Pallas's current strength is the combination of visible ongoing compounded prices, charge-on-prescription terms and a real menopause catalog. The right fit depends on whether the actual prescriber can coordinate the care you need and whether the selected four-week or annual payment commitment is comfortable.